Recoil Therapeutics
Company
An injectable platform designed to restore extracellular matrix mechanics and tissue elasticity. Initial indication: skin aging. Raising $2M pre-seed SAFE at $10M post-money cap.
Industries: Health, Biotechnology and Pharmaceuticals, Health, Heavy Industry and Engineering, Computers Electronics and Technology